Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 3, 1996, Pages 270-278

  Honnorat, Jérôme ^a   Antoine, Jean Christophe ^b   Derrington, Edmund ^a   Aguera, Michèle ^a   Belin, Marie Françoise ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b SERVICE DE NEUROLOGIE   (France)

Author keywords

Anti CV2 autoantibodies; Oligodendrocytes; Paraneoplastic neurological syndrome

Indexed keywords

ANTIBODY; AUTOANTIBODY; CELL ANTIGEN; MONOCLONAL ANTIBODY; PARAFORMALDEHYDE; PROTEIN;

ADULT; AGED; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY LABELING; ARTICLE; AUTOIMMUNITY; BRAIN STEM; CEREBELLUM; CEREBELLUM DEGENERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EATON LAMBERT SYNDROME; ENCEPHALITIS; FEMALE; GLIA CELL; HUMAN; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; MALE; MEDIASTINUM CANCER; MOLECULAR WEIGHT; NEUROLOGIC DISEASE; NONHUMAN; NORMAL HUMAN; OLIGODENDROGLIA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RAT; SERUM; SPINAL CORD; THYMOMA; UTERUS SARCOMA; WHITE MATTER;

EID: 0029790169     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.3.270     Document Type: Article

References (27)

1. Henson RA, Urich H. Paraneoplastic disorders. In : Henson RA, Urich H, eds. Cancer and the nervous system. Oxford: Blackwell Scientific Publications, 1982:311-621.
2. Posner JB, Dalmau J. Clinical enigmas of paraneoplastic neurological disorders. Clin Neurol Neurosurg 1995;97: 61-70.
3. Dalmau J, Posner JB. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology 1994;44:2241-6.
4. Lennon VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 1994;44: 2236-10.
5. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985:35:538-43.
6. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medecine 1992;71:59-72.
7. Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 1983-14:609-13.
8. Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992;42:1931-7.
9. Luque FA, Furneaux HM, Ferziger R, et al. Anti-Ri : an autoantibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991;29:241-51.
10. Anderson NE, Rosemblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Neurology 1988;24:559-67.
11. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc 1990;65:1423-31.
12. Hammack J, Kotanides H, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology 1992;42:1938-43.
13. Antoine JC, Honnorat J, Koenig F, et al. Posterior uveitis and paraneoplastic encephalomyelitis with auto-antibodies reacting against cytoplasmic proteins of brain and retina. J Neurol Sci 1993;117:215-23.
14. Antoine JC, Honnorat J, Thomas-Anterion C, et al. Limbic encephalitis and immunological perturbations in two patients with thymoma. J Neurol Neurosurg Psychiatry 1995;58:706-10.
15. Furneaux H, Rosenblum MK, Dalmau J, et al. Selective expression of Purkinje cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990;322:1844-51.
16. Friedman B, Hockfield S, Black JA, Woodruff KA, Waxman SG. In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, Rip. Glia 1989; 2:380-90.
17. Posner JB, Furneaux HM. Paraneoplastic syndromes. In: Waksman BH, ed. Immunologic mechanisms in neurologic and psychiatric diseases. New York: Raven Press, 1990: 187-219.
18. Ahern GL, O'Connor M, Dalmau J, et al. Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurology 1994;44:1270-4.
19. Darnell RB, DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993;341:21-2.
20. Anderson NE, Budde-Steffen C, Wiley RG, et al. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Neurology 1988;35: 1018-26.
21. Darnell RB, Furneaux HM, Posner JB. Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal rumors. J Neurosci 1991;11:1224-30.
22. Sher E, Canal L, Piccolo G, et al. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet 1989;2:640-3.
23. Greenlee JE, Brashear HR, Herndon RM. Immunoperpxidase labeling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia. J Neuropathol Exp Neurol 1988;47: 561-71.
24. Greenlee JE, Parks TN, Jaeckle KA. Type IIa (anti-Hu) antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro. Neurology 1993;43: 2049-54.
25. Hormigo A, Lieberman F. Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity. J Neuroimmunol 1994;55:205-12.
26. Jaekle KA. Autoimmune mechanisms in the pathogenesis of paraneoplastic nervous system disease. Clin Neurol Neurosurg 1995;97:82-8.
27. Lanska DJ. Diagnosis of thymorna in myasthenics using anti-striated muscle antibodies. Neurology 1991;41: 520-4.